Q3 2014
Released Nov 13, 2014, after the close
10-Q filed Nov 13, 2014, 44 days after period end · 0001144204-14-067701
Q3 2014 · 10-Q
Revenue$5.13M$5.13M −13.8% vs Q3 2013+185.5% vs Q2 2014
Net Income-$3.22M-$3.22M N/M vs Q3 2013N/M vs Q2 2014
EPS Diluted-$0.18-$0.18 N/M vs Q3 2013N/M vs Q2 2014
Gross Profit$3,510,000−8.0%
Operating Income-$3,215,000N/M
Operating Cash Flowderived-$2,442,000N/M
Free Cash Flowderived-$2,486,000N/M
Margins · derived
Gross margin68.4%+4.3 pt vs Q3 2013
Operating margin-62.7%−83.5 pt vs Q3 2013
Net margin-62.7%−83.5 pt vs Q3 2013
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Revenue | $5.13M | $5.95M | $5.42M | $5.08M |
| Net Income | -$3.22M | $1.24M | $1.07M | $1.11M |
| EPS Diluted | -$0.18 | $0.08 | $0.07 | $0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR